Key Takeaways

Doctors have begun the first clinical trial to test pig kidneys in human patients

The small trial will start with six people and may expand to 50 folks if early results are safe

More than 100,000 people in the U.S. need a kidney

WEDNESDAY, Nov. 5, 2025 (HealthDay News) — A first-of-its-kind clinical trial is beginning in the United States to see if pig kidneys could help save the lives of people waiting for a human organ transplant.

United Therapeutics , the company that developed the genetically edited pig kidneys, said Monday that the first transplant in the trial has already taken place at NYU Langone Health .

The patient’s identity and surgery date were not released for privacy reasons.

NYU surgeon Dr. Robert Montgomery , who led the transplant team, said the

See Full Page